Advertisement
Brief communication| Volume 48, ISSUE 5, P577-583, December 01, 1987

Resting myocardial ischemia after intravenous infusion of BM 13.177 (sulotroban), A thromboxane receptor antagonist

DOI:https://doi.org/10.1016/0049-3848(87)90389-6
Resting myocardial ischemia after intravenous infusion of BM 13.177 (sulotroban), A thromboxane receptor antagonist
Previous ArticleEffect of postprandial lipaemia on platelet function in man evaluated in whole blood
Next ArticleInhibition of the thrombocytopenic effect of exogenous and endogenous thrombin by PCR 4099 (d,1)methyl 2-(2-chlorophenyl)-2(4,5,6,7-tetrahydrothieno (3,2-c)pyridin-5-yl) acetate.hydrochloride.monohydrate.
      This paper is only available as a PDF. To read, Please Download here.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Tada M.
        • Kuzuya T.
        • Inoue M.
        • Kodama K.
        • Mishima M.
        • Yamada M.
        • Inui M.
        • Abe H.
        Elevation of thromboxane A2 levels in patients with classic and variant angina pectoris.
        Circulation. 1981; 64: 1107-1115
        • De Boer A.C.
        • Turpie A.G.G.
        • Butt R.W.
        • Johnston R.V.
        • Genton E.
        Platelet release and thromboxane synthesis in symptomatic coronary artery disease.
        Circulation. 1982; 66: 327-333
        • Mehta J.
        • Mehta P.
        • Feldman R.L.
        • Horalek C.
        Thromboxane release in coronary artery disease: Spontaneous versus pacing-induced angina.
        Am. Heart J. 1984; 107: 286-292
        • Fitzgerald D.J.
        • Roy L.
        • Catella F.
        • Fitzgerald G.A.
        Platelet activation in unstable coronary disease.
        N. Engl. J. Med. 1986; 315: 983-989
        • Lewis H.D.
        • Davis J.W.
        • Archibald D.G.
        • Steinke W.E.
        • Smitherman T.C.
        • Doherty III, J.E.
        • Schnaper H.W.
        • Lewinter M.M.
        • Linares E.
        • Pouget J.M.
        • Sabharwal S.C.
        • Chesler E.
        • Demots H.
        Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina.
        N. Engl. J. Med. 1983; 309: 396-403
        • Cairns J.A.
        • Gent M.
        • Singer J.
        • Finnie K.J.
        • Froggatt G.M.
        • Holder D.A.
        • Jablonsky G.
        • Kostuk W.J.
        • Melendez L.J.
        • Myers M.G.
        • Sacketp D.L.
        • Sealey B.J.
        • Tanser P.H.
        Aspirin, sulfinpyrazone, or both in unstable angina.
        N. Engl. J. Med. 1985; 313: 1369-1375
        • Lewy R.I.
        • Wiener L.
        • Walinsky P.
        • Lefer A.M.
        • Silver M.J.
        • Smith J.B.
        Thromboxane release during pacing induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.
        Circulation. 1980; 61: 1165-1171
        • Thaulow E.
        • Dale J.
        • Myhre E.
        Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary heart disease.
        Am. J. Cardiol. 1984; 53: 1255-1258
        • Stegmeier K.
        • Pill J.
        • Mulleer-Beckmann B.
        • Schmidt F.H.
        • Witte E.C.
        • Wolff H.P.
        • Patscheke H.
        The pharmacological profile of the thromboxane A2 antagonist BM 13.177.
        Thrombosis Res. 1984; 35: 379-395
        • Gresele P.
        • Deckmyn H.
        • Arnout J.
        • Lemmens J.
        • Janssens W.
        • Vermylen J.
        BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man.
        Lancet. 1984; I: 991-994
        • Riess H.
        • Hiller E.
        • Reinhardt B.
        • Brauning C.
        Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic disease.
        Thrombosis Res. 1984; 35: 371-378
        • Kupper W.
        • Bleifeld W.
        Regionale und globale KoronarsinusfluB-messungen mit dem kontinuierlichen Thermodilutionsverfahren.
        in: Methode and experimentelle Untersuchungen. Z. Kardiol.68. 1979: 740-747
        • Durliat H.
        • Comtat M.
        • Baudras A.
        Spectrophotometric and electrochemical determinations of L(+)-lactate in blood by use of lactate dehydrogenase from yeast.
        Clin. Chem. 1976; 22: 1802-1805

      Article info

      Publication history

      Accepted: September 29, 1987
      Received: August 11, 1987

      Identification

      DOI: https://doi.org/10.1016/0049-3848(87)90389-6

      Copyright

      © 1987 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX